Global Listeriosis Infection Treatment Market, By Drugs Class (Ampicillin, Gentamicin, Vancomycin, and Others), Indication Type (Bacterial Meningitis, Endocarditis, and Others), Strain Type (Listeria Monocytogenes, Listeria Innocua, Listeria Welshimeri, and Others), Mode of Administration (Injectable, Oral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, and Others) - Industry Trends and Forecast to 2030.
Listeriosis Infection Treatment Market Analysis and Size
The global listeriosis infection treatment market refers to the demand for drugs and therapies for treating listeriosis, a severe bacterial infection caused by Listeria monocytogenes. This market includes various pharmaceutical products and treatment approaches to manage and combat the disease.
Data Bridge Market Research analyses that the Listeriosis Infection Treatment market was valued at USD 4,501.34 million in 2022 and is expected to reach the value of USD 6,481.58 million by the year 2030, at a CAGR of 5.20% during the forecast period. “Ampicillin” dominates the drug class segment of the listeriosis infection treatment market owing to the increasing prevalence of cardiac arrhythmias. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Listeriosis Infection Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Drugs Class (Ampicillin, Gentamicin, Vancomycin, and Others), Indication Type (Bacterial Meningitis, Endocarditis, and Others), Strain Type (Listeria Monocytogenes, Listeria Innocua, Listeria Welshimeri, and Others), Mode of Administration (Injectable, Oral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Peru, Brazil, Argentina, and rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of Middle East and Africa.
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson (U.S.), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (U.S.), Edenbridge Pharmaceuticals, LLC (U.S.), ParaPRO LLC (U.S.), Encube Ethicals (India), GALDERMA (Switzerland), Alliance Pharmaceuticals (U.K.), Foamix Pharmaceuticals Ltd (U.S.), Arbor Pharmaceuticals (U.S.), Dr. Reddy's Laboratories Ltd. (India), Perrigo Company plc (Ireland).among others.
|
|
Market Opportunities
|
|
Market Definition
The listeriosis infection treatment market refers to the global industry focused on diagnosing, preventing, and treating infections caused by Listeria monocytogenes. This bacterium can cause a severe condition known as listeriosis. Listeriosis is especially dangerous for pregnant women, newborns, the elderly, and individuals with weakened immune systems.
Listeriosis Infection Treatment Market Dynamics
Drivers
- Rising Incidence of Listeriosis
The increasing number of listeriosis cases worldwide is a significant driver for the market. Factors such as improper food handling practices, contaminated food products, and a growing population at risk contribute to the rising incidence of listeriosis infections.
- Growing Awareness about Listeriosis
Increasing awareness among individuals, healthcare professionals, and regulatory authorities regarding listeriosis and its potential risks drives the demand for effective treatment. Awareness campaigns, educational initiatives, and improved diagnostic methods contribute to early detection and prompt treatment.
- Advancements in Treatment Options
Advances in medical research and technology have led to the development of new treatment options for listeriosis infection. These include the discovery of novel antimicrobial agents, improved drug delivery systems, and the development of targeted therapies, all of which contribute to the market's growth.
Opportunities
The government initiatives, schemes, or funding that support and promote the innovation and development of the Listeriosis Infection Treatment market provide growth opportunities for the market players from 2023 to 2030. Additionally, the development of innovative therapies, expansion of healthcare infrastructure, penetration rate, market expansion in developing countries, and increasing per capita expenditure on healthcare will further expand the market's growth rate in the future.
Challenges/ Restraints
- High Cost of Treatment
The cost of treating listeriosis infection, including hospitalization, medications, and supportive care, can be substantial. This high cost poses a challenge for patients, particularly in regions with limited healthcare resources and low-income populations.
- Regulatory Hurdles
The stringent regulatory requirements and approval processes associated with developing and commercializing new treatment options for listeriosis can pose challenges for pharmaceutical companies. Compliance with regulatory standards and demonstrating the safety and efficacy of novel therapies require significant investments of time and resources. Also, the global impact of pandemics, patient compliance, and education, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market growth.
This listeriosis infection treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the listeriosis infection treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2017, the U.S. Food and Drug Administration suggested the R&D of a new therapeutic approach for treating listeria monocytogenes infection to address the outbreak in the U.S.
Global Listeriosis Infection Treatment Market Scope
The listeriosis infection treatment market is segmented on the basis of drug class, indication type, strain type, mode of administration, distribution channel, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drugs Class
- Ampicillin
- Gentamicin
- Vancomycin
- Others
Indication Type
- Bacterial Meningitis
- Endocarditis
- Others
Strain Type
- Listeria Monocytogenes
- Listeria Innocua
- Listeria Welshimeri
- Others
Mode of Administration
- Oral
- Intravenous
- Others
End-Users
- Homecare
- Specialty Clinics
- Hospital
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Listeriosis Infection Treatment Market Regional Analysis/Insights
The market is analysed, and market size insights and trends are provided by country, drug class, indication type, strain type, mode of administration, distribution channel, and end user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Peru, Brazil, Argentina, and rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of Middle East and Africa.
North America dominates the listeriosis infection treatment market due to the high acceptance of advanced medicines and therapies within the region. Asia-Pacific is expected to witness high growth during the forecast period of 2021 to 2028 because of the economic growth in the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The listeriosis infection treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for listeriosis infection treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the listeriosis infection treatment market. The data is available for historic period 2010-2021.
Competitive Landscape and Listeriosis Infection Treatment Market Share Analysis
The listeriosis infection treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to listeriosis infection treatment market.
Some of the major players operating in the listeriosis infection treatment market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Sanofi (France),
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Johnson & Johnson (U.S.)
- Bayer AG (Germany)
- Sun Pharmaceutical Industries Ltd. (India)
- Eli Lilly and Company (U.S.)
- Edenbridge Pharmaceuticals, LLC (U.S.)
- ParaPRO LLC (U.S.)
- Encube Ethicals (India)
- GALDERMA (Switzerland)
- Alliance Pharmaceuticals (U.K.)
- Foamix Pharmaceuticals Ltd (U.S.)
- Arbor Pharmaceuticals (U.S.)
- Dr. Reddy's Laboratories Ltd. (India)
- Perrigo Company plc (Ireland)
SKU-